Company intelligence / Profile preview

Frontline Ventures

Shanghai, Shanghai, China6dimensionscapital.com ↗

Ownership: Private
Development stage: Other

Overview

Frontline BioVentures was a prominent venture capital firm dedicated to the life sciences and healthcare sectors, with a strategic focus on the Chinese and U.S. markets. Established in 2012, the firm specialized in identifying and nurturing high-potential companies in biotechnology, pharmaceuticals, and medical technology. In 2017, Frontline BioVentures merged with WuXi Healthcare Ventures to form 6 Dimensions Capital, creating one of the world's largest healthcare-focused investment platforms. The firm's portfolio included notable successes such as Innovent Biologics and Hua Medicine, playing a key role in the maturation of the Chinese biotech ecosystem.

Industry: Investors

Partnerships

WuXi AppTec

Beyond the preview

Go deeper on Frontline Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Frontline Ventures.

Explore the full profile